Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PLSE · against 261 other Healthcare companies of similar size
Ranked #245 of 262 · scores higher than 6% of peers
Bars: peers in each 10-point band of the growth score18 peers with a growth score of 0–9, including PLSE · Click a bar to see the companies
Mainly because of its 3-year revenue growth and earnings per share growth, which are weaker than most Healthcare peers.
| Metric | PLSE | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 261 reported | Not reported | 8.0% | — | — | 33% |
| Earnings per share growthHigher is better · 166 reported | Not reported | 12.0% | — | — | 33% |
| 3-year revenue growthHigher is better · 256 reported | -20.6% | 8.7% | 5% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 2 | 2.8B USD | 99 | 51 | |
| 2 | 15.6B DKK (≈$2.3B) | 99 | 96 | |
| 238 | 3.1B USD | 12 | 27 | |
| 243 | 29.2B CNY (≈$4.1B) | 11 | 42 | |
| 244 | 15.0B CNY (≈$2.1B) | 10 | 55 | |
| 245 | 26.5B CNY (≈$3.7B) | 9 | 69 | |
| 245 | 3.7B USD | 9 | 24 | |
| 245 | 5.7B USD | 9 | 38 | |
| 248 | 3.7B USD | 8 | 31 | |
| 248 | 2.4B USD | 8 | 27 | |
| 248 | 2.4B USD | 8 | 20 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score